N-Acetyl Glucosamine and Reduced Composite Fecal Biomarker Score

• Malnutrition enteropathy in Zambian and Zimbabwean children with severe acute malnutrition: A multi-arm randomized phase II trial.

  • 2024-04-17
  • RCT · n = 143
  • Nature communications 15(1)
  • • Kanta Chandwe
    • Mutsa Bwakura-Dangarembizi
    • Beatrice Amadi
    • Gertrude Tawodzera
    • Deophine Ngosa
    • Anesu Dzikiti
    • Nivea Chulu
    • Robert Makuyana
    • Kanekwa Zyambo
    • Kuda Mutasa
    • Chola Mulenga
    • Ellen Besa
    • Jonathan P Sturgeon
    • Shepherd Mudzingwa
    • Bwalya Simunyola
    • Lydia Kazhila
    • Masuzyo Zyambo
    • Hazel Sonkwe
    • Batsirai Mutasa
    • Miyoba Chipunza
    • Virginia Sauramba
    • Lisa Langhaug
    • Victor Mudenda
    • Simon H Murch
    • Susan Hill
    • Raymond J Playford
    • Kelley VanBuskirk
    • Andrew J Prendergast
    • Paul Kelly

  • PubMed: 38632262
  • DOI: 10.1038/s41467-024-45528-0

  1 Insight on

  • Reduced Composite Fecal Biomarker Score

  • High evidence
  • Large Human Trial
  • Rigorous Journal
  • Clinical

  N-acetyl glucosamine (-0.20 (-1.01, 0.60) P = 0.67) had no significant effect

  Effect

  Neutral

  Effect size

  Small

  Significant

  No